145 related articles for article (PubMed ID: 2530765)
1. The therapeutic efficacy of paroxetine: (a) an open study in patients with major depression not responding to antidepressants; (b) a double-blind comparison with amitriptyline in depressed outpatients.
Gagiano CA; Müller PG; Fourie J; Le Roux JF
Acta Psychiatr Scand Suppl; 1989; 350():130-1. PubMed ID: 2530765
[No Abstract] [Full Text] [Related]
2. A double-blind, multicentre study of paroxetine versus clomipramine in depressed elderly patients.
Guillibert E; Pelicier Y; Archambault JC; Chabannes JP; Clerc G; Desvilles M; Guibert M; Pagot R; Poisat JL; Thobie Y
Acta Psychiatr Scand Suppl; 1989; 350():132-4. PubMed ID: 2530766
[No Abstract] [Full Text] [Related]
3. A double-blind study to compare the effectiveness and tolerability of paroxetine and amitriptyline in depressed patients.
Bascara L
Acta Psychiatr Scand Suppl; 1989; 350():141-2. PubMed ID: 2530771
[No Abstract] [Full Text] [Related]
4. A double-blind study of the comparative antidepressant effect of paroxetine and amitriptyline.
Kuhs H; Rudolf GA
Acta Psychiatr Scand Suppl; 1989; 350():145-6. PubMed ID: 2530773
[No Abstract] [Full Text] [Related]
5. A double-blind comparison of paroxetine and placebo in the treatment of depressed patients in a psychiatric outpatient clinic.
Miller SM; Naylor GJ; Murtagh M; Winslow G
Acta Psychiatr Scand Suppl; 1989; 350():143-4. PubMed ID: 2530772
[No Abstract] [Full Text] [Related]
6. Paroxetine in the treatment of depression: a comparison with imipramine and placebo.
Feighner JP; Boyer WF
Acta Psychiatr Scand Suppl; 1989; 350():125-9. PubMed ID: 2530763
[TBL] [Abstract][Full Text] [Related]
7. Paroxetine: a selective serotonin reuptake inhibitor showing better tolerance, but weaker antidepressant effect than clomipramine in a controlled multicenter study. Danish University Antidepressant Group.
J Affect Disord; 1990 Apr; 18(4):289-99. PubMed ID: 2140382
[TBL] [Abstract][Full Text] [Related]
8. Platelet 5-HT transport in depressed patients under double-blind treatment with paroxetine versus amitriptyline.
Schlake HP; Kuhs H; Rolf LH; Bosse T; Schuhknecht E; Rudolf GA; Brune GG
Acta Psychiatr Scand Suppl; 1989; 350():149-51. PubMed ID: 2530775
[No Abstract] [Full Text] [Related]
9. Meta-analysis of early phase II studies with paroxetine in hospitalized depressed patients.
Byrne MM
Acta Psychiatr Scand Suppl; 1989; 350():138-9. PubMed ID: 2530768
[No Abstract] [Full Text] [Related]
10. A double-blind, multicentre study of paroxetine and mianserin in depression.
Mertens C; Pintens H
Acta Psychiatr Scand Suppl; 1989; 350():140. PubMed ID: 2530770
[No Abstract] [Full Text] [Related]
11. Relationship between parameters of serotonin transport and antidepressant plasma levels or therapeutic response in depressive patients treated with paroxetine and amitriptyline.
Kuhs H; Schlake HP; Rolf LH; Rudolf GA
Acta Psychiatr Scand; 1992 May; 85(5):364-9. PubMed ID: 1534961
[TBL] [Abstract][Full Text] [Related]
12. A placebo-controlled, double-blind, clinical trial of paroxetine in depressed outpatients.
Rickels K; Amsterdam J; Clary C; Fox I; Schweizer E; Weise C
Acta Psychiatr Scand Suppl; 1989; 350():117-23. PubMed ID: 2530761
[TBL] [Abstract][Full Text] [Related]
13. A double-blind, placebo-controlled study of paroxetine in depressed outpatients.
Kiev A
J Clin Psychiatry; 1992 Feb; 53 Suppl():27-9. PubMed ID: 1531818
[TBL] [Abstract][Full Text] [Related]
14. A comparison of paroxetine, imipramine and placebo in depressed out-patients.
Dunbar GC; Cohn JB; Fabre LF; Feighner JP; Fieve RR; Mendels J; Shrivastava RK
Br J Psychiatry; 1991 Sep; 159():394-8. PubMed ID: 1835664
[TBL] [Abstract][Full Text] [Related]
15. The short- and long-term efficacy of paroxetine HCl: A. Data from a 6-week double-blind parallel design trial vs. imipramine and placebo.
Peselow ED; Filippi AM; Goodnick P; Barouche F; Fieve RR
Psychopharmacol Bull; 1989; 25(2):267-71. PubMed ID: 2532373
[No Abstract] [Full Text] [Related]
16. The efficacy and safety of paroxetine compared with placebo in outpatients with major depression.
Rickels K; Amsterdam J; Clary C; Fox I; Schweizer E; Weise C
J Clin Psychiatry; 1992 Feb; 53 Suppl():30-2. PubMed ID: 1531820
[TBL] [Abstract][Full Text] [Related]
17. Paroxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depressive illness.
Dechant KL; Clissold SP
Drugs; 1991 Feb; 41(2):225-53. PubMed ID: 1709852
[TBL] [Abstract][Full Text] [Related]
18. The safety and efficacy of paroxetine compared with placebo in a double-blind trial of depressed outpatients.
Claghorn JL
J Clin Psychiatry; 1992 Feb; 53 Suppl():33-5. PubMed ID: 1531821
[TBL] [Abstract][Full Text] [Related]
19. Paroxetine in the treatment of depression: a comparison with imipramine and placebo.
Feighner JP; Boyer WF
J Clin Psychiatry; 1992 Feb; 53 Suppl():44-7. PubMed ID: 1531824
[TBL] [Abstract][Full Text] [Related]
20. The effect of paroxetine on the electroencephalogram, electrocardiogram, and blood pressure.
Edwards JG; Goldie A; Papayanni-Papasthatis S; Punter J; Sedgwick EM
Acta Psychiatr Scand Suppl; 1989; 350():124. PubMed ID: 2530762
[No Abstract] [Full Text] [Related]
[Next] [New Search]
